Pulmonx Logo.png
Pulmonx Reports Third Quarter 2022 Financial Results
November 03, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Logo.png
Pulmonx to Report Third Quarter 2022 Financial Results on November 3, 2022
October 20, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Logo.png
Pulmonx Reports Second Quarter 2022 Financial Results
August 02, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Logo.png
Pulmonx Reports First Quarter 2022 Financial Results
May 03, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Logo.png
Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference
April 26, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Logo.png
Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022
April 19, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Logo.png
Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today...
Pulmonx Logo.png
Pulmonx to Present at the Citi 2022 Virtual Healthcare Conference
February 10, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...
Pulmonx Logo.png
Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 09, 2022 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it...
Pulmonx Logo.png
Pulmonx to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021 16:05 ET | Pulmonx Corporation
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the...